ClinVar Miner

Submissions for variant NM_015272.5(RPGRIP1L):c.583A>T (p.Lys195Ter)

gnomAD frequency: 0.00004  dbSNP: rs1277577195
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000812456 SCV000952770 pathogenic Familial aplasia of the vermis; Meckel-Gruber syndrome 2023-11-05 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Lys195*) in the RPGRIP1L gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPGRIP1L are known to be pathogenic (PMID: 17558409). This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with RPGRIP1L-related conditions. ClinVar contains an entry for this variant (Variation ID: 591393). For these reasons, this variant has been classified as Pathogenic.
Revvity Omics, Revvity RCV000722572 SCV002019896 likely pathogenic not provided 2022-06-20 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002507274 SCV002815208 likely pathogenic Joubert syndrome 7; Meckel syndrome, type 5; COACH syndrome 3 2022-05-10 criteria provided, single submitter clinical testing
Gharavi Laboratory, Columbia University RCV000722572 SCV000853703 uncertain significance not provided 2018-09-16 no assertion criteria provided research
Natera, Inc. RCV001273840 SCV001457425 pathogenic Familial aplasia of the vermis 2020-09-16 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV004733019 SCV005362396 likely pathogenic RPGRIP1L-related disorder 2024-05-13 no assertion criteria provided clinical testing The RPGRIP1L c.583A>T variant is predicted to result in premature protein termination (p.Lys195*). To our knowledge, this variant has not been reported in individuals affected with RPGRIP1L-related conditions in the literature. This variant is reported in 0.0065% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in RPGRIP1L are expected to be pathogenic. This variant is interpreted as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.